{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T17:07:27Z","timestamp":1789578447223,"version":"build-2803163510"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1097\/aog.0b013e3181b96ec6","type":"journal-article","created":{"date-parts":[[2009,9,16]],"date-time":"2009-09-16T03:14:10Z","timestamp":1253070850000},"page":"736-743","source":"Crossref","is-referenced-by-count":66,"title":["Are Uterine Risk Factors More Important Than Nodal Status in Predicting Survival in Endometrial Cancer?"],"prefix":"10.1097","volume":"114","author":[{"given":"Janice S.","family":"Kwon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Refik","family":"Saskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark S.","family":"Carey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210126","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1002\/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO;2-8","article-title":"Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study.","volume":"60","author":"Creasman","year":"1987","journal-title":"Cancer"},{"key":"R2-6-20210126","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1006\/gyno.1995.1005","article-title":"Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling.","volume":"56","author":"Kilgore","year":"1995","journal-title":"Gynecol Oncol"},{"key":"R3-6-20210126","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1006\/gyno.2001.6276","article-title":"Long-term survival of intermediate risk endometrial cancer (stage IG3, IC, II) treated with full lymphadenectomy and brachytherapy without teletherapy.","volume":"82","author":"Fanning","year":"2001","journal-title":"Gynecol Oncol"},{"key":"R4-6-20210126","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0029-7844(97)00698-4","article-title":"Surgery without radiotherapy for primary treatment of endometrial cancer.","volume":"91","author":"Larson","year":"1998","journal-title":"Obstet Gynecol"},{"key":"R5-6-20210126","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1006\/gyno.1998.5098","article-title":"Long-term outcomes of therapeutic pelvic lymphadenectomy for stage I endometrial adenocarcinoma.","volume":"70","author":"Mohan","year":"1998","journal-title":"Gynecol Oncol"},{"key":"R6-6-20210126","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0002-9378(97)70601-X","article-title":"Stage I corpus cancer: is teletherapy necessary?","volume":"176","author":"Orr","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"R7-6-20210126","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0090-8258(03)00085-4","article-title":"High-risk surgical stage 1 endometrial cancer: outcomes with vault brachytherapy alone.","volume":"89","author":"Rittenberg","year":"2003","journal-title":"Gynecol Oncol"},{"key":"R8-6-20210126","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1006\/gyno.2001.6494","article-title":"Conservative management of stage I endometrial carcinoma after surgical staging.","volume":"84","author":"Straughn","year":"2002","journal-title":"Gynecol Oncol"},{"key":"R9-6-20210126","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1200\/JCO.2004.00.7617","article-title":"Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study.","volume":"24","author":"Randall","year":"2006","journal-title":"J Clin Oncol"},{"key":"R10-6-20210126","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1093\/jnci\/djn397","article-title":"Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.","volume":"100","author":"Benedetti Panici","year":"2008","journal-title":"Journal Natl Cancer Inst"},{"key":"R11-6-20210126","first-page":"125","article-title":"Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study [published erratum appears in Lancet 2009;373:1764].","volume":"373","author":"Kitchener","year":"2009","journal-title":"Lancet"},{"key":"R12-6-20210126","first-page":"419","article-title":"Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients.","volume":"56","author":"Aalders","year":"1980","journal-title":"Obstet Gynecol"},{"key":"R13-6-20210126","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0140-6736(00)02139-5","article-title":"Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma.","volume":"355","author":"Creutzberg","year":"2000","journal-title":"Lancet"},{"key":"R14-6-20210126","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ygyno.2003.11.048","article-title":"A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study [published erratum appears in Gynecol Oncol 2004;94:241-2].","volume":"92","author":"Keys","year":"2004","journal-title":"Gynecol Oncol"},{"key":"R15-6-20210126","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ygyno.2007.09.029","article-title":"Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study.","volume":"108","author":"Susumu","year":"2008","journal-title":"Gynecol Oncol"},{"key":"R16-6-20210126","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1097\/01.AOG.0000262897.21628.06","article-title":"Cost-effectiveness analysis of strategies for the surgical management of grade 1 endometrial adenocarcinoma.","volume":"109","author":"Cohn","year":"2007","journal-title":"Obstet Gynecol"},{"key":"R17-6-20210126","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.ygyno.2004.03.002","article-title":"Cost-effectiveness analysis of the treatment for intermediate risk endometrial cancer: postoperative brachytherapy vs. observation.","volume":"93","author":"Fanning","year":"2004","journal-title":"Gynecol Oncol"},{"key":"R18-6-20210126","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S1701-2163(16)32387-8","article-title":"Cost-effectiveness analysis of treatment strategies for Stage I and II endometrial cancer.","volume":"29","author":"Kwon","year":"2007","journal-title":"J Obstet Gynaecol Can"},{"key":"R19-6-20210126","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ygyno.2007.08.072","article-title":"A cost-effective analysis of adjuvant therapies for the treatment of stage I endometrial adenocarcinoma.","volume":"108","author":"Lachance","year":"2008","journal-title":"Gynecol Oncol"},{"key":"R20-6-20210126","doi-asserted-by":"crossref","first-page":"LBA5503","DOI":"10.1200\/jco.2008.26.15_suppl.lba5503","article-title":"Vaginal brachytherapy versus external beam pelvic radiotherapy for high-intermediate risk endometrial cancer: results of the randomized PORTEC-2 trial.","volume":"26","author":"Nout","year":"2008","journal-title":"J Clin Oncol"},{"key":"R21-6-20210126","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1525-1438.2007.00812.x","article-title":"Patterns of practice and outcomes in intermediate- and high-risk stage I and II endometrial cancer: a population-based study.","volume":"17","author":"Kwon","year":"2007","journal-title":"Int J Gynecol Cancer"},{"key":"R22-6-20210126","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.","volume":"45","author":"Deyo","year":"1992","journal-title":"J Clin Epidemiol"},{"key":"R24-6-20210126","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/0002-9378(85)90371-0","article-title":"Risk factors and recurrent patterns in Stage I endometrial cancer.","volume":"151","author":"DiSaia","year":"1985","journal-title":"Am J Obstet Gynecol"},{"key":"R25-6-20210126","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0090-8258(91)90086-K","article-title":"Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study.","volume":"40","author":"Morrow","year":"1991","journal-title":"Gynecol Oncol"},{"key":"R26-6-20210126","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1200\/JCO.2004.08.159","article-title":"Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the Postoperative Radiation Therapy in Endometrial Carcinoma Trial.","volume":"22","author":"Creutzberg","year":"2004","journal-title":"J Clin Oncol"},{"key":"R27-6-20210126","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.1200\/jco.2007.25.18_suppl.5503","article-title":"A randomized phase-III study on adjuvant treatment with radiation (RT) +\/- chemotherapy (CT) in early-stage high-risk endometrial cancer (NSGO-EC-9501\/EORTC 55991).","volume":"25","author":"Hogberg","year":"2007","journal-title":"J Clin Oncol"},{"key":"R28-6-20210126","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1525-1438.2007.00996.x","article-title":"The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology.","volume":"18","author":"Chi","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"R29-6-20210126","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ygyno.2005.11.032","article-title":"Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology.","volume":"102","author":"Lutman","year":"2006","journal-title":"Gynecol Oncol"},{"key":"R30-6-20210126","first-page":"87","article-title":"What is the number of lymph nodes required for an \u201cadequate\u201d pelvic lymphadenectomy?","volume":"25","author":"Nijman","year":"2004","journal-title":"European J Gynaecol Oncol"},{"key":"R31-6-20210126","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1200\/JCO.2005.04.144","article-title":"Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer.","volume":"23","author":"Cragun","year":"2005","journal-title":"J Clin Oncol"},{"key":"R32-6-20210126","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1463-1318.2007.01225.x","article-title":"The impact of surgeon and pathologist on lymph node retrieval in colorectal cancer and its impact on survival for patients with Dukes\u2019 stage B disease.","volume":"10","author":"Evans","year":"2008","journal-title":"Colorectal Dis"},{"key":"R33-6-20210126","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1200\/JCO.2007.11.0445","article-title":"Identifying stage III colorectal cancer patients: the influence of the patient, surgeon, and pathologist.","volume":"25","author":"Morris","year":"2007","journal-title":"J Clin Oncol"},{"key":"R34-6-20210126","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1463-1318.2004.00670.x","article-title":"What factors affect lymph node yield in surgery for rectal cancer?","volume":"6","author":"Thorn","year":"2004","journal-title":"Colorectal Dis"},{"key":"R35-6-20210126","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/jnci\/dji020","article-title":"Lymph node evaluation in colorectal cancer patients: a population-based study.","volume":"97","author":"Baxter","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"R38-6-20210126","first-page":"230","article-title":"Adjuvant therapy for high-risk adenocarcinoma of the uterus.","author":"Fleming","year":"2008","journal-title":"ASCO Educational Book"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006250-200910000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:02:07Z","timestamp":1786039327000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006250-200910000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0b013e3181b96ec6","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}